These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36729318)

  • 41. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients.
    Lalani T; Federspiel JJ; Boucher HW; Rude TH; Bae IG; Rybak MJ; Tonthat GT; Corey GR; Stryjewski ME; Sakoulas G; Chu VH; Alder J; Steenbergen JN; Luperchio SA; Campion M; Woods CW; Fowler VG
    J Clin Microbiol; 2008 Sep; 46(9):2890-6. PubMed ID: 18596141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
    Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
    Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.
    Vidal PM; Trindade PA; Garcia TO; Pacheco RL; Costa SF; Reinert C; Hiramatsu K; Mamizuka EM; Garcia CP; Levin AS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):139-45. PubMed ID: 19146463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia.
    Siméon S; Le Moing V; Tubiana S; Duval X; Fournier D; Lavigne JP; Erpelding ML; Gustave CA; Desage S; Chirouze C; Vandenesch F; Tattevin P;
    Clin Microbiol Infect; 2019 Apr; 25(4):481-488. PubMed ID: 30036664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of methicillin resistance with mortality of hospital-acquired
    Aratani T; Tsukamoto H; Higashi T; Kodawara T; Yano R; Hida Y; Iwasaki H; Goto N
    J Int Med Res; 2021 Nov; 49(11):3000605211058872. PubMed ID: 34826374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Active surveillance to determine the impact of methicillin resistance on mortality in patients with bacteremia and influences of the use of antibiotics on the development of MRSA infection.
    Porto JP; Santos RO; Gontijo Filho PP; Ribas RM
    Rev Soc Bras Med Trop; 2013; 46(6):713-8. PubMed ID: 24474012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores.
    Park SY; Son JS; Oh IH; Choi JM; Lee MS
    Infection; 2011 Apr; 39(2):141-7. PubMed ID: 21424856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
    Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
    J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Hsu RB
    Infect Control Hosp Epidemiol; 2005 Jul; 26(7):654-7. PubMed ID: 16092748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.
    Butler-Laporte G; Cheng MP; Cheng AP; McDonald EG; Lee TC
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7444-7448. PubMed ID: 27736763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors influencing clinical outcome in Staphylococcus aureus bacteraemia in a Turkish University Hospital.
    Topeli A; Unal S; Akalin HE
    Int J Antimicrob Agents; 2000 Feb; 14(1):57-63. PubMed ID: 10717502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Community-Onset Methicillin-Resistant
    Bae E; Kim CK; Jang JH; Sung H; Choi Y; Kim MN
    Ann Lab Med; 2019 Mar; 39(2):158-166. PubMed ID: 30430778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance.
    Steinberg JP; Clark CC; Hackman BO
    Clin Infect Dis; 1996 Aug; 23(2):255-9. PubMed ID: 8842259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    Shurland S; Zhan M; Bradham DD; Roghmann MC
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):273-9. PubMed ID: 17326017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxic Shock Syndrome Toxin 1-Producing Methicillin-Resistant Staphylococcus aureus of Clonal Complex 5, the New York/Japan Epidemic Clone, Causing a High Early-Mortality Rate in Patients with Bloodstream Infections.
    Kim D; Hong JS; Yoon EJ; Lee H; Kim YA; Shin KS; Shin JH; Uh Y; Shin JH; Park YS; Jeong SH
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bacteremia by Staphylococcus aureus: analysis of 311 episodes].
    Rubio M; Romero J; Corral O; Roca V; Picazo JJ
    Enferm Infecc Microbiol Clin; 1999 Feb; 17(2):56-64. PubMed ID: 10193063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method.
    Wang JL; Wang JT; Sheng WH; Chen YC; Chang SC
    BMC Infect Dis; 2010 Jun; 10():159. PubMed ID: 20529302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.